These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Elevated surfactant protein A in bronchoalveolar lavage fluids from sarcoidosis and hypersensitivity pneumonitis patients. Hamm H; Lührs J; Guzman y Rotaeche J; Costabel U; Fabel H; Bartsch W Chest; 1994 Dec; 106(6):1766-70. PubMed ID: 7988197 [TBL] [Abstract][Full Text] [Related]
4. The motility of lung lymphocytes in hypersensitivity pneumonitis and sarcoidosis. Ohtsuka M; Yoshizawa Y; Naitou T; Yano H; Sato T; Hasegawa S Am J Respir Crit Care Med; 1994 Feb; 149(2 Pt 1):455-9. PubMed ID: 8306045 [TBL] [Abstract][Full Text] [Related]
5. Differential expression of alpha E beta 7 integrins on bronchoalveolar lavage T lymphocyte subsets: regulation by alpha 4 beta 1-integrin crosslinking and TGF-beta. Rihs S; Walker C; Virchow JC; Boer C; Kroegel C; Giri SN; Braun RK Am J Respir Cell Mol Biol; 1996 Nov; 15(5):600-10. PubMed ID: 8918367 [TBL] [Abstract][Full Text] [Related]
6. Idiopathic pulmonary fibrosis. Abnormalities in the bronchoalveolar lavage content of surfactant protein A. McCormack FX; King TE; Voelker DR; Robinson PC; Mason RJ Am Rev Respir Dis; 1991 Jul; 144(1):160-6. PubMed ID: 2064123 [TBL] [Abstract][Full Text] [Related]
7. Enhanced tissue factor pathway activity and fibrin turnover in the alveolar compartment of patients with interstitial lung disease. Günther A; Mosavi P; Ruppert C; Heinemann S; Temmesfeld B; Velcovsky HG; Morr H; Grimminger F; Walmrath D; Seeger W Thromb Haemost; 2000 Jun; 83(6):853-60. PubMed ID: 10896238 [TBL] [Abstract][Full Text] [Related]
8. [Measurement of total glutathione concentration in bronchoalveolar lavage recovered from the patients with diffuse interstitial lung disease]. He QY; Ishii Y; Kitamura S Zhonghua Jie He He Hu Xi Za Zhi; 1994 Feb; 17(1):24-6, 61. PubMed ID: 8082213 [TBL] [Abstract][Full Text] [Related]
9. Increased surfactant protein A content in human alveolar macrophages in hypersensitivity pneumonitis. Guzman J; Wang YM; Kalaycioglu O; Schoenfeld B; Hamm H; Bartsch W; Costabel U Acta Cytol; 1992; 36(5):668-73. PubMed ID: 1523923 [TBL] [Abstract][Full Text] [Related]
10. Human bronchoalveolar lavage fluid protein two-dimensional database: study of interstitial lung diseases. Wattiez R; Hermans C; Cruyt C; Bernard A; Falmagne P Electrophoresis; 2000 Jul; 21(13):2703-12. PubMed ID: 10949149 [TBL] [Abstract][Full Text] [Related]
11. Elevated levels of thymus- and activation-regulated chemokine in bronchoalveolar lavage fluid from patients with eosinophilic pneumonia. Miyazaki E; Nureki S; Fukami T; Shigenaga T; Ando M; Ito K; Ando H; Sugisaki K; Kumamoto T; Tsuda T Am J Respir Crit Care Med; 2002 Apr; 165(8):1125-31. PubMed ID: 11956056 [TBL] [Abstract][Full Text] [Related]
12. Alveolar macrophage membrane phospholipid methylation in sarcoidosis and hypersensitivity pneumonitis. Pacheco Y; Fonlupt P; Rey C; Biot N; Vergnon JM; Douss T; Pacheco H; Perrin-Fayolle M Bull Eur Physiopathol Respir; 1986; 22(6):565-72. PubMed ID: 3828547 [TBL] [Abstract][Full Text] [Related]
13. Suppressive mechanisms of alveolar macrophages in interstitial lung diseases: role of soluble factors and cell-to-cell contact. Fireman E; Ben-Efraim S; Spinrad S; Topilsky M; Greif J Eur Respir J; 1993 Jul; 6(7):956-64. PubMed ID: 8370444 [TBL] [Abstract][Full Text] [Related]
14. [Extracellular components of broncho-alveolar lavage fluid (BALF) as markers of interstitial pulmonary disease activity. II. Phospholipid concentration]. Zielonka TM; Wałajtys-Rode E; Jasińska R; Chazan R; Droszcz W Przegl Lek; 1998; 55(12):654-8. PubMed ID: 10354716 [TBL] [Abstract][Full Text] [Related]
15. Surfactant modifies the lymphoproliferative activity of macrophages in hypersensitivity pneumonitis. Israël-Assayag E; Cormier Y Am J Physiol; 1997 Dec; 273(6):L1258-64. PubMed ID: 9435582 [TBL] [Abstract][Full Text] [Related]
16. Flow cytometric detection of cell-associated interleukin-8 in alveolar macrophages in vivo from patients with hypersensitivity pneumonitis and sarcoidosis. Fujishima S; Nakamura M; Nakamura H; Inoue T; Yogo Y; Okubo Y; Aikawa N; Kanazawa M; Yamaguchi K Scand J Clin Lab Invest; 2004; 64(3):237-43. PubMed ID: 15222634 [TBL] [Abstract][Full Text] [Related]
17. Angiogenic and angiostatic chemokines in idiopathic pulmonary fibrosis and granulomatous lung disease. Cui A; Anhenn O; Theegarten D; Ohshimo S; Bonella F; Sixt SU; Peters J; Sarria R; Guzman J; Costabel U Respiration; 2010; 80(5):372-8. PubMed ID: 19816001 [TBL] [Abstract][Full Text] [Related]
18. A possible alteration of surfactant in broncho-alveolar lavage fluid from healthy smokers compared to non-smokers and patients with sarcoidosis. Zetterberg G; Curstedt T; Eklund A Sarcoidosis; 1995 Mar; 12(1):46-50. PubMed ID: 7617976 [TBL] [Abstract][Full Text] [Related]
19. [Delayed nonspecific cutaneous hypersensitivity in extrinsic allergic alveolitis and idiopathic pulmonary fibrosis]. Orriols R; Drobnic ME; Sampol G; Ferrer J; Román A; Morell F Med Clin (Barc); 1991 Apr; 96(16):611-3. PubMed ID: 2051829 [TBL] [Abstract][Full Text] [Related]
20. Hepatocyte growth factor in bronchoalveolar lavage fluids and cells in patients with inflammatory chest diseases of the lower respiratory tract: detection by RIA and in situ hybridization. Sakai T; Satoh K; Matsushima K; Shindo S; Abe S; Abe T; Motomiya M; Kawamoto T; Kawabata Y; Nakamura T; Nukiwa T Am J Respir Cell Mol Biol; 1997 Apr; 16(4):388-97. PubMed ID: 9115749 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]